Functionally
modified aptamer conjugates are promising tools for
targeted imaging or treatment of various diseases. However, broad
applications of aptamer molecules are limited by their in
vivo instability. To overcome this challenge, current strategies
mostly rely on covalent chemical modification of aptamers, a complicated
process that requires case-by-case sequence design, multiple-step
synthesis, and purification. Herein, we report a covalent modification-free
strategy to enhance the in vivo stability of aptamers.
This strategy simply utilizes one-step molecular engineering of aptamers
with gold nanoclusters (GNCs) to form GNCs@aptamer self-assemblies.
Using Sgc8 as a representative aptamer, the resulting GNCs@Sgc8 assemblies
enhance cancer-cell-specific binding and sequential internalization
by a receptor-mediated endocytosis pathway. Importantly, the GNCs@aptamer
self-assemblies resist nuclease degradation for as long as 48 h, compared
to the degradation of aptamer alone at 3 h. In parallel, the tumor-targeted
recognition and retention of GNCs@aptamer self-assemblies are dramatically
enhanced, indicated by a 9-fold signal increase inside the tumor compared
to the aptamer alone. This strategy is to avoid complicated chemical
modification of aptamers and can be extended to all aptamers. Our
work provides a simple, effective, and universal strategy for enhancing
the in vivo stability of any aptamer or its conjugates,
thus expanding their imaging and therapeutic applications.